OPEN END TURBO OPTIONSSCHEIN LONG - BECTON DICKINSON AND CO. Share Price

Certificat

DE000GK9PNS3

Real-time BOERSE MUENCHEN 09:56:08 03/06/2024 pm IST
8.46 EUR +8.18% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - BECTON DICKINSON AND CO.
1 month-7.02%
3 months-8.86%
Date Price Change
03/24/03 8.46 +8.18%
31/24/31 7.82 +5.39%
30/24/30 7.42 +0.27%
29/24/29 7.4 -1.46%
28/24/28 7.51 -1.83%

Real-time BOERSE MUENCHEN

Last update June 03, 2024 at 09:56 pm IST

More quotes

Static data

Product typeWarrant Knock-Out senza Stop Loss
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Goldman Sachs
WKN GK9PNS
ISINDE000GK9PNS3
Date issued 26/08/2022
Strike 145.7 $
Maturity Unlimited
Parity 10 : 1
Emission price 13.04
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 13.58
Lowest since issue 7.2
Spread 0.02
Spread %0.24%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232 USD
Average target price
278.7 USD
Spread / Average Target
+20.14%
Consensus